RNA Outsourcing Resources

  1. How Operational Efficiency Shapes Late-Phase Manufacturability 6/26/2026

    Prioritize operational efficiency over early-stage flexibility to scale advanced therapies. Standardized workflows and qualified shipping lanes reduce variability for predictable late-phase success.

  2. The Execution Stage Of Technology Transfer 5/2/2024

    What are the key elements in the readiness stage of a technology transfer that are critical to your success? Explore Process Performance Qualification (PPQ) and the execution stage of PDA TR-65.

  3. Enabling The Outcome Through Enhancing Patient Accessibility 4/28/2025

    To ensure that the transformative potential of cell and gene therapy reaches every patient in need, we must prioritize equitable access and overcome the remaining barriers to widespread delivery.

  4. Where Innovation Is Moving The Advanced Therapies Supply Chain 4/28/2026

    Assimilate how advanced therapy supply chains are evolving toward patient-centric, risk-managed, digitally connected models to support scale, reliability, and regulatory confidence globally today.

  5. Validate Cryopreservation As A Defined Input, Not A Variable 4/28/2026

    Treating cryopreservation as a validated, controlled input improves consistency, quality, and patient outcomes by reducing variability across cell therapy manufacturing, storage, and distribution.

  6. Reflecting On 2024: A Year Of Groundbreaking Achievements 1/8/2025

    Partner with us to drive life-changing therapies forward and support families worldwide with innovative supply chain solutions for life sciences.

  7. Starting Smart: Building Early CGT Supply Chains 6/26/2025

    Discover how building a scalable, compliant supply chain can set your CGT program up for long-term success and avoid risks that could derail progress down the line.

  8. Supercharge Your Supply Chain: Harness AI To Gain Competitive Advantage

    The success of CGTs hinges upon adherence to specific logistics protocols. Learn how the integration of AI in the pharma supply chain is poised to enhance visibility, efficiency, and compliance.

  9. Scaling For What's Next In EMEA 12/29/2025

    Scaling cell and gene therapy operations in EMEA demands strategic planning, regulatory alignment, and robust logistics to meet growing demand and ensure consistent delivery across diverse markets.

  10. Improvement Of Self-Amplifying RNA Quality And Potency With IVT Optimization 2/4/2026

    Explore our study on optimizing In-Vitro Transcription (IVT) conditions for self-amplifying RNAs to achieve high yields, low residual dsRNA, and improved potency, and learn how these advancements can enhance RNA-based therapies.